How does dietary fibre affect the gut microbiome and health?

What it is

Dietary fibres are carbohydrates that reach the colon, where gut bacteria can ferment them. Types studied include fructans (inulin, fructooligosaccharides), galacto-oligosaccharides, resistant starches, psyllium and wheat bran, and different chemical structures feed different bacteria.

What the research says

Across 64 trials, fibre supplements (especially fructans and galacto-oligosaccharides) raised stool Bifidobacterium and Lactobacillus but did not change alpha-diversity; a pooled reanalysis even found fibre reduced alpha-diversity in the short term, and fibre explained only about 1.5% of microbiome variation versus 82% for the individual. Specific resistant-starch structures shifted butyrate or propionate output predictably. For clinical outcomes, cohort data associate the highest fibre intakes with 15-30% lower mortality, heart disease, type 2 diabetes and colorectal cancer (moderate certainty), and trials show lower weight, blood pressure and cholesterol. In IBS, psyllium helps while bran can worsen symptoms.

Evidence grade: Well established.

What goes wrong

In a primary-care IBS trial, 10 g wheat bran was not significantly better than placebo in the worst-case analysis, and early dropout was most common with bran because IBS symptoms worsened. (Source 1)

• Randomized trial, Moderate certainty.
• Size: 275 patients (bran n = 97)
• Who: adults 18-65 with IBS, Dutch general practice.
• How long: 12 weeks.
• Result: bran month 3 RR 1.70 (1.12-2.57), worst case 1.45 (0.97-2.16); dropouts mainly due to worsened symptoms.
• Funding: Netherlands Organisation for Health Research and Development (independent)

Early dropout was most common in the bran group; the main reason was that the symptoms of irritable bowel syndrome worsened.

What the evidence supports

Fibre supplementation, particularly fructans and galacto-oligosaccharides, increased stool Bifidobacterium and Lactobacillus in healthy adults. (Source 2)

• Meta-analysis, Moderate certainty.
• Size: 64 RCTs, 2,099 participants.
• Who: healthy adults.
• How long: varied.
• Result: Bifidobacterium SMD 0.64 (95% CI 0.42 to 0.86); Lactobacillus SMD 0.22 (0.03 to 0.41) after excluding an outlier study (from the abstract, not in the quoted passage)
• Funding: not stated on the page we fetched.

Dietary fiber intervention, particularly involving fructans and galacto-oligosaccharides, leads to higher fecal abundance of Bifidobacterium and Lactobacillus spp.

In a dose-response trial, structurally different type-IV resistant starches produced distinct, consistent shifts toward propionate or butyrate production, plateauing at 35 g/day. (Source 3)

• Randomized trial, Low certainty.
• Size: not stated in abstract.
• Who: healthy humans.
• How long: not stated in abstract.
• Result: structure-specific shifts; dose effect plateaued at 35 g/day.
• Funding: not stated.

crystalline and phosphate cross-linked starch structures induce divergent and highly specific effects on microbiome composition

Across 185 cohort studies and 58 trials, the highest fibre consumers had 15-30% lower all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes and colorectal cancer (observational); trials showed lower bodyweight, systolic blood pressure and total cholesterol. (Source 4)

• Systematic review, Moderate certainty.
• Size: 185 prospective studies (~135 million person-years) and 58 trials (4,635 adults)
• Who: general adult population, excluding people with chronic disease.
• How long: varied.
• Result: 15-30% risk reduction; greatest at 25-29 g/day.
• Funding: Health Research Council of New Zealand, WHO and others (independent)

Observational data suggest a 15–30% decrease in all-cause and cardiovascular related mortality

In IBS, fibre supplements increased clinical response overall, with a specific benefit for psyllium. (Source 5)

• Meta-analysis, Moderate certainty.
• Size: 30 RCTs, 1,904 people; 16 RCTs (n = 1,293) for response.
• Who: adults with IBS.
• How long: varied.
• Result: 52% vs 44% responded, RR 1.21 (95% CI 1.03-1.41); psyllium RR 1.53 (1.06-2.19)
• Funding: not stated on page fetched.

with a benefit for psyllium specifically (risk ratio, 1.53; 95% CI, 1.06 to 2.19)

What the evidence does not support

The same meta-analysis found fibre did not affect alpha-diversity. (Source 2)

• Meta-analysis, Moderate certainty.
• Size: 64 RCTs, 2,099 participants.
• Who: healthy adults.
• How long: varied.
• Result: no effect on alpha-diversity.
• Funding: not stated.

leads to higher fecal abundance of Bifidobacterium and Lactobacillus spp. but does not affect α-diversity

In the Stanford trial, a high-fibre diet increased microbial carbohydrate-degrading enzymes but microbial community diversity stayed stable. (Source 6)

• Randomized trial, Low certainty.
• Size: 36 randomized (18 per arm)
• Who: healthy adults.
• How long: 17 weeks.
• Result: diversity stable.
• Funding: not stated.

The high-fiber diet increased microbiome-encoded glycan-degrading carbohydrate active enzymes (CAZymes) despite stable microbial community diversity

The same IBS meta-analysis found no significant effect of fibre on overall GI symptom scores, except for beta-galacto-oligosaccharides. (Source 5)

• Meta-analysis, Low certainty.
• Size: 9 RCTs, n = 497.
• Who: adults with IBS.
• How long: varied.
• Result: SMD -0.25 (95% CI -0.67 to 0.17), P = .25, I2 = 78%.
• Funding: not stated.

Nine RCTs (n = 497) reported overall GI symptoms (integrative scores) and found no significant effect

Where the evidence is mixed

A reanalysis of raw sequencing data from 21 fibre interventions found fibre produced consistent taxon shifts but explained only about 1.5% of compositional variation and reduced alpha-diversity. (Source 7)

• Meta-analysis, Low certainty.
• Size: 538 subjects, 2,564 stool samples, 12 studies.
• Who: healthy individuals.
• How long: short-term.
• Result: 1.5% of variation from fibre vs 82% from the individual; alpha-diversity reduced.
• Funding: not stated.

Increased fiber consumption explained an average of 1.5% of compositional variation (vs 82% of variation attributed to the individual), reduced alpha-diversity

In a 2025 preprint trial, the high-fibre group (with dried chicory root) showed a significant decrease in microbial diversity versus control, while raising butyrate-producing genera and speeding gut transit. (Source 8)

• Randomized trial, Low certainty.
• Size: 147 adults.
• Who: healthy adults.
• How long: 8 weeks.
• Result: diversity decreased; transit time reduced (p = 0.01); sleep quality improved (p = 0.03)
• Funding: Dutch Digestive Health Fund; industry-affiliated authors.

whereas the HDF group showed a significant decrease

The Lancet review graded certainty as moderate for fibre and noted findings apply to the general population, not to people with chronic disease. (Source 4)

• Systematic review, Moderate certainty.
• Size: as above.
• Who: general population.
• How long: varied.
• Result: GRADE moderate.
• Funding: independent.

The certainty of evidence for relationships between carbohydrate quality and critical outcomes was graded as moderate for dietary fibre

Where the research disagrees

Does fibre increase gut microbiome diversity?

• So et al. 2018 meta-analysis, meta-analysis of 64 RCTs: but does not affect α-diversity (Source 2)
• Rodriguez et al. 2024 reanalysis, pooled reanalysis of 21 interventions: Increased fiber consumption explained an average of 1.5% of compositional variation (vs 82% of variation attributed to the individual), reduced alpha-diversity (Source 7)

A common belief, and what the research shows

The belief: Eating more fibre increases gut microbiome diversity.

What the research shows: Meta-analytic evidence says fibre raises specific genera "but does not affect α-diversity", and a pooled reanalysis found short-term fibre "reduced alpha-diversity". Health benefits of fibre are supported by other evidence, graded "moderate for dietary fibre".

Questions and answers

What is it?

Dietary fibres are carbohydrates that gut bacteria can ferment. Types tested include fructans, galacto-oligosaccharides, resistant starches, psyllium and bran; their chemical structure matters for which bacteria respond. (Source 5)

What does it do in the body?

Fibre shifts specific bacteria (Bifidobacterium, Lactobacillus) and can steer short-chain fatty acid output, but explains only a small share of microbiome variation between people. (Source 3)

Is it good or bad for you?

Higher fibre intake is associated with lower mortality and chronic disease risk (moderate certainty). Some fibres can worsen symptoms in IBS, as wheat bran did in one trial. (Source 4)

How do you get more of it?

Trials raised fibre through diet or supplements; the Lancet review found risk reduction was greatest at 25-29 g a day. This is what the studies report, not advice. (Source 4)

If it is harmful, what reduces it?

Does not apply: fibre is not harmful in general. In IBS, the trial evidence favours psyllium over bran. (Source 1)

Why might someone be low in it or missing it?

Low intake is the main reason; the Stanford authors describe lower microbiome diversity as pervasive in industrialized society. The reviews we fetched did not quantify intake gaps. (Source 6)

Which whole foods contain it or feed it?

Whole grains are the best-studied whole food alongside fibre, with similar findings. Chicory root was used to raise fibre in one trial. (Source 4)

What happens if you do not have it?

In cohort studies, the lowest fibre consumers had higher rates of death, heart disease, type 2 diabetes and colorectal cancer than the highest; this is association, graded moderate certainty. (Source 4)

How can you test for it, and how reliable is that test?

No validated test for fibre status exists in the literature we searched; research uses stool sequencing, and fibre explains little of the variation between people. (Source 7)

We searched: WebSearch for fibre microbiome meta-analyses; AJCN, mSystems, Lancet abstracts

References

1. BMJ. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. 2009. PMID 19713235, DOI 10.1136/bmj.b3154. Read the source
2. American Journal of Clinical Nutrition. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. 2018. PMID 29757343, DOI 10.1093/ajcn/nqy041. Read the source
3. Cell Host & Microbe. Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production. 2020. PMID 32004499, DOI 10.1016/j.chom.2020.01.006. Read the source
4. The Lancet. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. 2019. PMID 30638909, DOI 10.1016/S0140-6736(18)31809-9. Read the source
5. Gastroenterology. Fiber Supplementation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2026. DOI 10.1053/j.gastro.2026.07.027. Read the source
6. Cell. Gut-microbiota-targeted diets modulate human immune status. 2021. PMID 34256014, DOI 10.1016/j.cell.2021.06.019. Read the source
7. mSystems. Short-term dietary fiber interventions produce consistent gut microbiome responses across studies. 2024. DOI 10.1128/msystems.00133-24. Read the source
8. medRxiv. Distinct modulatory effects of high-fiber and fermented-food diets on gut microbiota, immune function, transit time, and sleep quality in a citizen science randomized controlled trial (preprint). 2025. DOI 10.1101/2025.08.05.25332853. Read the source